Gsk (GSK) Free Cash Flow (2009 - 2026)
Gsk (GSK) recorded Free Cash Flow of $2.12 billion in the quarter ended Mar 31, 2026, up 11.4% from $1.9 billion a year earlier.
Powered by 
Analysis
Gsk (GSK) Free Cash Flow (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's Free Cash Flow came in at -$998.54 million as of Mar 31, 2026; for the year ended Dec 31, 2025, it came in at $8.43 billion, up 27.9% from the prior year.
- Annual Free Cash Flow has a five-year compound annual growth rate of -2.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Free Cash Flow came in at $6.59 billion in the year ended Dec 31, 2024 (-2.9%), $6.78 billion in the year ended Dec 31, 2023 (-12.4%), $7.75 billion in the year ended Dec 31, 2022 (-19.6%) and $9.63 billion in the year ended Dec 31, 2021 (+0.7%).
- The figure for the quarter ended Mar 31, 2026 is the highest quarterly Free Cash Flow since the quarter ended Sep 30, 2024.
- On a year-over-year basis, Free Cash Flow rose in three of the last four quarters, with growth averaging 2.5%.
- Peak year-over-year performance for Free Cash Flow in the last five years was growth of 338.8% in the quarter ended Mar 31, 2022, against a decline of 80.4% in the quarter ended Mar 31, 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,267.62 Bn | 1,241.24 Bn | 20.46 Bn | 8.22 Bn |
| 2 | Johnson & Johnson | 666.76 Bn | 586.62 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 520.19 Bn | 488.20 Bn | 13.12 Bn | 7.31 Bn |
| 4 | Merck | 370.06 Bn | 324.43 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 319.62 Bn | 292.86 Bn | - | - |
| 6 | Astrazeneca | 293.19 Bn | 267.08 Bn | 13.26 Bn | 7.96 Bn |
| 7 | Amgen | 257.73 Bn | 213.13 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 217.04 Bn | 192.15 Bn | 6.73 Bn | 4.80 Bn |
| 9 | Pfizer | 174.90 Bn | 121.55 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Gsk | 103.42 Bn | 86.26 Bn | 8.73 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Bn |
| Dec 31, 2025 | -3.77 Bn |
| Mar 31, 2025 | 1.90 Bn |
| Dec 31, 2024 | -1.25 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 261.88 Mn |
| Mar 31, 2023 | 632.06 Mn |
| Dec 31, 2022 | 964.15 Mn |
| Mar 31, 2022 | 3.22 Bn |
| Dec 31, 2021 | 3.38 Bn |
| Mar 31, 2021 | 733.59 Mn |
| Dec 31, 2020 | 2.84 Bn |
| Mar 31, 2020 | 1.49 Bn |
| Dec 31, 2019 | 1.80 Bn |
| Sep 30, 2019 | 3.45 Bn |
| Mar 31, 2019 | 1.15 Bn |
| Dec 31, 2018 | 2.49 Bn |
| Mar 31, 2018 | 1.56 Bn |
| Dec 31, 2017 | 415.56 Mn |
| Sep 30, 2017 | 2.97 Bn |
API Access
Gsk Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();